Rad Viva offers expert interpretation of High-Resolution CT (HRCT) chest scans, essential for diagnosing interstitial lung diseases (ILD), post-infectious changes, and diffuse pulmonary pathologies. Our radiologists follow structured reporting formats based on internationally accepted guidelines to ensure diagnostic precision and clarity.
We assist pulmonologists and referring physicians with timely, pattern-based assessments tailored to clinical context.
Each HRCT chest scan is reviewed using thin-section imaging protocols. We evaluate for reticulations, ground-glass opacities, fibrosis, nodules, traction bronchiectasis, and honeycombing. Patterns are classified according to guidelines such as the ATS/ERS criteria for ILD or COVID-19-specific CT severity indices (if applicable).
All reports include anatomical distribution, disease pattern, differential considerations, and follow-up recommendations.
We report HRCT chest studies for ILD, hypersensitivity pneumonitis, sarcoidosis, post-COVID fibrosis, pneumoconiosis, and other diffuse lung diseases.
Yes. Reports are structured with pattern classification (e.g., UIP, probable UIP, NSIP) based on updated radiological guidelines.
Yes. We include CT severity scoring and reporting for infectious lung diseases such as COVID-19, where requested.
Providing structured radiology reporting and CoreLab analysis for diagnostic centers, hospitals, and research organizations.
Email : info@radviva.com
Phone: +91-9844314454
Explore
Note: All services are provided remotely. Physical visits are not applicable.